Insights from 2023 EHA® Annual Meeting

 

Insights from 2023 EHA® Annual Meeting
C

2023 EHA® Insights: "Matching-Adjusted Indirect Comparison of Zanubrutinib vs. Ibrutinib in R/R MZL"

By Insights from 2023 EHA® Annual Meeting FEATURING Catherine Thieblemont
By Insights from 2023 EHA® Annual Meeting FEATURING Catherine Thieblemont
61 views
July 6, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal
Lymphoma
10:42

EHA® 2023 Insights: "Epcoritamab With Rituximab + Lenalidomide in Pa…

Insights from 2023 EHA® Annual Meeting

A. Sureda

44 views
02:18

2023 EHA® Insights: "Matching-Adjusted Indirect Comparison of Zanubr…

Insights from 2023 EHA® Annual Meeting

C. Thieblemont

61 views